RXI-109-1301: A Multi-Center, Prospective, Randomized, Double-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Scar Revision Surgery on Transverse Hypertrophic Scars on the Lower Abdome

Project: Research project

Project Details

StatusFinished
Effective start/end date11/27/1311/27/16

Funding

  • RXi Pharmaceuticals Corporation (RXI-109-1301)